Multimodality treatment of locally advanced breast cancer

R. Lionetto, P. Pronzato, P. F. Conte, D. Amoroso, F. Badellino, G. Bertelli, G. Canavese, G. Gardin, R. Rosso

Research output: Contribution to journalArticlepeer-review


From 1976 to 1985, 61 consecutive patients with locally advanced breast cancer were treated with multimodality therapy. Overall 5-year survival was 30% with a median survival of 36 months. 50% of patients relapsed within 13 months. Other factors such as menopausal status, side of illness (right or left breast), responses to systemic or to local treatment, survival and progression-free survival in responders and non-responders have been analyzed.

Original languageEnglish
Pages (from-to)137-141
Number of pages5
Issue number3
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Multimodality treatment of locally advanced breast cancer'. Together they form a unique fingerprint.

Cite this